)
Redsense Medical (REDS) investor relations material
Redsense Medical Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Net sales grew 34% year-over-year to KSEK 6,402, driven by increased adoption and broader customer mix, especially in the U.S. market.
Operating profit (EBIT) reached KSEK 1,077, a turnaround from a loss of KSEK -3,152 in Q1 2025.
Gross margin improved to 76%, reflecting higher disposable sales and operational efficiency.
Cash position at quarter-end was KSEK 9,738, with an unused credit facility of KSEK 1,000.
First commercial sale of the Clamp System in the UK and positive pilot results in Germany signal international expansion.
Financial highlights
Net sales: KSEK 6,402 (up from 4,776 year-over-year).
EBIT: KSEK 1,077 (up from -3,152 year-over-year).
Earnings per share: SEK 0.07 (up from -0.19 year-over-year).
Gross profit: KSEK 4,879 (up from 2,219 year-over-year).
Cash flow from operating activities: KSEK 2,760 (up from 761 year-over-year).
Outlook and guidance
Focus remains on disciplined execution, increasing U.S. end-customer usage, progressing Clamp rollout, and expanding into new markets.
Operational improvements and revised U.S. pricing structure expected to support continued growth and broader adoption.
- Sales fell and losses widened in 2025, with focus shifting to U.S. growth and margin recovery.REDS
Q4 202519 Feb 2026 - Q3 2025 saw 38% sales growth, improved EBIT, and key product launches amid global expansion.REDS
Q3 202519 Nov 2025 - Q2 sales fell 28% but H1 sales grew 6% year-over-year, with strong cash and new product launches.REDS
Q2 202520 Aug 2025 - Sales stable, losses widened, cash up; strong Q4 expected with new product launch.REDS
Q3 202413 Jun 2025 - Record sales and strategic investment position Redsense for growth in home hemodialysis.REDS
Q2 202413 Jun 2025 - Net sales up 179% year-over-year; Clamp launch and US focus drive future growth.REDS
Q1 20256 Jun 2025 - Record sales and first full-year profit signal strong momentum for Redsense Medical.REDS
Q4 20245 Jun 2025
Next Redsense Medical earnings date
Next Redsense Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage